PharmChem (PCHM) Stock Price, News & Analysis

Company Overview

PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

Key Stats

• Today's Range: $3.40 to $3.40
• 50-Day Range: $3.05 to $3.54
• 52-Week Range: $2.51 to $4.00
• Volume: N/A
• Average Volume: 725 shs
• Market Capitalization: $15.81 million
• P/E Ratio: 11.72
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PCHM Stock Analysis - Frequently Asked Questions

How have PCHM shares performed this year?

PharmChem's stock was trading at $3.06 at the beginning of 2025. Since then, PCHM stock has increased by 11.1% and is now trading at $3.40.
View the best growth stocks for 2025 here.

How were PharmChem's earnings last quarter?

PharmChem, Inc. (OTCMKTS:PCHM) announced its quarterly earnings results on Friday, November, 8th. The company reported $0.08 EPS for the quarter. The firm had revenue of $1.57 million for the quarter.

How do I buy shares of PharmChem?

Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/08/2024
• Today: 2/22/2025
• Next Earnings (Estimated): 4/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical laboratories
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:PCHM
• CUSIP: N/A
• CIK: N/A
• Web: www.pharmchek.com
• Phone: (855) 458-4100
• Fax: 817-605-6400
• Employees: 170
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.29
• Trailing P/E Ratio: 11.72
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $850,000.00
• Net Margins: 23.32%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $6.01 million
• Price / Sales: 2.63
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,650,000
• Free Float: 3,839,000
• Market Cap: $15.81 million
• Optionable: Not Optionable
• Beta: 0.68